Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Can focal nodular hyperplasia transform into hepatocellular carcinoma? A 20-year journey from benign to malignant.

Created on 03 Jul 2026

Authors

Lydia Renardson, Hassaan Bari, Jawad Ahmad

Published in

BMJ case reports. Volume 19. Issue 7. Jul 02, 2026. Epub Jul 02, 2026.

Abstract

This case presents a progression from benign focal nodular hyperplasia (FNH) to hepatocellular carcinoma (HCC) in a middle-aged patient undergoing private testosterone therapy for andropause. The patient presented to their general practitioner with fatigue and pruritus; routine blood tests showed deranged liver function tests. Historical records indicated a large FNH lesion that was stable for decades and required no intervention.Subsequent imaging demonstrated a mass within the right lobe suggestive of malignant transformation. Multidisciplinary discussion concluded the lesion likely represented HCC or hepatic adenoma. The patient underwent a successful robotic right hemihepatectomy. Histopathology confirmed well-differentiated HCC with macroscopic vascular invasion (pT2N0M0). Postoperative imaging showed no evidence of recurrence or metastasis, and liver function returned to normal.This case underscores the potential for malignant transformation in large FNH-like lesions despite prolonged radiological stability. It emphasises the role of imaging surveillance and robotic surgery as effective curative strategies.

PMID:
42392677
Bibliographic data and abstract were imported from PubMed on 03 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement